上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。
SEL120-34A
SEL120-34A 是一种有效的,选择性的,可口服的,ATP-竞争性的 CDK8 抑制剂,对 CDK8/CycC 和 CDK19/CycC 的 IC50 值分别为 4.4 nM 和 10.4 nM,具有抗肿瘤活性。
SEL120-34A Chemical Structure
CAS No. : 1609522-33-9
规格 | 是否有货 | ||
---|---|---|---|
100 mg | 询价 | ||
250 mg | 询价 | ||
500 mg | 询价 |
* Please select Quantity before adding items.
SEL120-34A 的其他形式现货产品:
生物活性 |
SEL120-34A is a potent, selective, orally available, ATP-competitive CDK8 inhibitor, with IC50s of 4.4 nM and 10.4 nM for CDK8/CycC and CDK19/CycC, respectively, with antitumor activity. |
|||
---|---|---|---|---|
IC50 & Target[1] |
|
|||
体外研究 (In Vitro) |
SEL120-34A is a selective, ATP-competitive CDK8 inhibitor, with IC50 of 4.4 nM and 10.4 nM for CDK8/CycC and CDK19/CycC, respectively. SEL120-34A shows no obvious inhibition on CDK1, 2, 4, 6, 5, 7, and only weakly suppresses CDK9 (IC50, 1070 nM). SEL120-34A is active against a panel of AML cell lines (GI50<1 μm), such as skno-1, kg-1, hel-60, molm-16, mv-4-11, ociaml-2, molm-6 and ociaml-3 cells, consistent with the effective inhibition range of stat1 s727 stat5 s726[1]. Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only. |
|||
体内研究 (In Vivo) |
SEL120-34A (30, 60 mg/kg, p.o.) inhibits the growth of tumor in mice bearing MV4-11 cancer cells, and also arrests the growth of KG-1-derived tumors at 30 mg/kg via oral administration[1]. Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only. |
|||
分子量 |
414.14 |
|||
Formula |
C15H18Br2N4 |
|||
CAS 号 |
1609522-33-9 |
|||
运输条件 |
Room temperature in continental US; may vary elsewhere. |
|||
储存方式 |
Please store the product under the recommended conditions in the Certificate of Analysis. |
|||
参考文献 |
|
所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务